Abstract: A method to determine medication adherence may include detecting whether a wearable electronic device is in use. The method may include detecting one or more markers in sweat vapor of the user using a chemical marker sensor of the wearable electronic device. The method may include, in response to detecting that the system is in use, determining whether the user has taken a therapeutic agent that includes the one or more markers based on detecting the one or more markers in the sweat vapor.

Abstract: The present disclosure generally relates to the determination of blood pressure of a human being. More specifically, but not exclusively, in one aspect the present disclosure relates to determination of blood pressure of a human being over an extended period of time. In one form, a method for determining a blood pressure value of a human being includes determining a period of time during which the human being is stationary. The method also includes determining, during the period of time, a plurality of measurements providing pulse-related data values from the human being. From the plurality of measurements, a representative pulse-related data value representative of the pulse-related data values determined during the period of time may be determined. The method also includes determining, from the representative pulse-related data value, a blood pressure value of the human being for the period of time.

Abstract: An adhesive device may include a first adhesive surface configured to be adhered to skin of a user, and a second adhesive surface opposite the first adhesive surface and configured to be adhered to a medical device. The adhesive device may also include an intermediate region between the first adhesive surface and the second adhesive surface, where the intermediate region includes a detector compound embedded in the intermediate region configured to change based on interaction of the detector compound with a target molecule.

Abstract: A method to measure sound-producing behaviors of a subject with a power- and bandwidth-limited electronic device that includes a processor includes measuring, by a microphone communicatively coupled to the processor, sound in a vicinity of the subject to generate an audio data signal that represents the sound. The method also includes measuring, by at least one second sensor communicatively coupled to the processor, at least one parameter other than sound to generate at least a second data signal that represents the at least one parameter other than sound. The method also includes detecting one or more sound-producing behaviors of the subject based on: both the audio data signal and the second data signal; or information derived from both the audio data signal and the second data signal.

Abstract: According to an aspect of an embodiment, a method may include obtaining, at a mobile biometric-data hub, a first biometric reading of a user. The method may also include, based on the first biometric reading, associating the mobile biometric-data hub with the user. The method may also include wirelessly receiving, at the mobile biometric-data hub, a second biometric reading from a biometric sensor distinct from the mobile biometric-data hub. The method may also include determining that the second biometric reading is of the user. The method may also include, based on the second biometric reading being of the user and based on the association between the mobile biometric-data hub and the user, tagging the second biometric reading with an identifier of the user. The method may also include communicating the tagged second biometric reading from the mobile biometric-data hub to a network-attached device.

Abstract: A system to determine medication adherence may include a chemical marker sensor, a verification sensor, and a processor. The chemical marker sensor may be configured to detect one or more markers in sweat vapor of a user. The verification sensor may be configured to detect whether the system is in use. The processor may be communicatively coupled to the chemical marker sensor and the verification sensor and may be configured to determine whether the user has taken a therapeutic agent that includes the one or more markers based on signals generated by the chemical marker sensor and the verification sensor.

Abstract: A system to measure sweat vapor may include a skin contact sensor, a sweat vapor sensor, and a processor. The skin contact sensor may be configured to measure one or more aspects indicative of whether the measuring device is in contact with skin of a user of the measuring device. The sweat vapor sensor may be configured to measure one or more properties of sweat vapor of the user; and the processor may be communicatively coupled to the skin contact sensor and the sweat vapor sensor. The processor may be configured to confirm operation of the measuring device based on the one or more aspects measured by the skin contact sensor, and the sweat vapor sensor receiving the sweat vapor.

Abstract: A method to create autonomous decision logic (ADL) may include receiving a request to create the ADL. The request includes a selection of an input and a selection of an output. When executed by a client device, the ADL is configured to provide the output based at least partially on an identification of the input. The method further includes electronically packaging the input and the output to generate the ADL. The method includes sending the ADL via a transport layer to the client device for execution of the ADL on the client device. The client device is configured to generate encrypted data pertaining to the execution of the ADL. The method includes receiving, from the client device, the encrypted data pertaining to the execution of the ADL. The method further includes decrypting the encrypted data. The method includes presenting at least some of the decrypted data on a display.